CA1084064A - Method for preparing 2'-(carboxymethoxy)-chalcones - Google Patents

Method for preparing 2'-(carboxymethoxy)-chalcones

Info

Publication number
CA1084064A
CA1084064A CA271,121A CA271121A CA1084064A CA 1084064 A CA1084064 A CA 1084064A CA 271121 A CA271121 A CA 271121A CA 1084064 A CA1084064 A CA 1084064A
Authority
CA
Canada
Prior art keywords
methyl
ulcer
butenyloxy
gastric
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA271,121A
Other languages
English (en)
French (fr)
Inventor
Kazuaki Kyogoku
Sadakazu Yokomori
Katsuo Hatayama
Jiro Sawada
Ichiro Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of CA1084064A publication Critical patent/CA1084064A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA271,121A 1976-02-13 1977-02-04 Method for preparing 2'-(carboxymethoxy)-chalcones Expired CA1084064A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1457876A JPS5297950A (en) 1976-02-13 1976-02-13 Chalconeether derivatives
JP14578/76 1976-02-13

Publications (1)

Publication Number Publication Date
CA1084064A true CA1084064A (en) 1980-08-19

Family

ID=11865033

Family Applications (1)

Application Number Title Priority Date Filing Date
CA271,121A Expired CA1084064A (en) 1976-02-13 1977-02-04 Method for preparing 2'-(carboxymethoxy)-chalcones

Country Status (12)

Country Link
US (1) US4085135A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5297950A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR209544A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1084064A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH605537A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2705603C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES455620A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2340924A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1523241A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU173019B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT66118B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU39378B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4190671A (en) * 1977-03-17 1980-02-26 Biorex Laboratories Limited Chalcone derivatives
JPS5552597U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1978-09-30 1980-04-08
JPS62207212A (ja) * 1986-03-08 1987-09-11 Nippon Haipotsukusu:Kk 抗アレルギ−剤
US5089654A (en) * 1989-08-08 1992-02-18 Taisho Pharmaceutical Co., Ltd. Chalcone derivatives
AU742787B2 (en) 1997-07-09 2002-01-10 Androsolutions, Inc. Improved methods and compositions for treating male erectile dysfunction
US6103765A (en) * 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
KR20030031500A (ko) * 2000-06-20 2003-04-21 아테로제닉스, 인코포레이티드 1,3-비스-(치환된-페닐)-2-프로펜-1-온 및 ｖｃａｍ-1매개된 질환을 치료하기 위한 그의 용도
AU2002248910A1 (en) 2000-11-17 2002-05-27 Idenix (Cayman) Limited Methods for inhibiting the transmission of HIV using topically applied substituted 6-benzyl-4-oxopyrmidines
HUP0500165A2 (en) * 2001-12-19 2006-09-28 Atherogenics Inc Chalcone derivatives and their use to treat diseases
WO2004056727A2 (en) * 2002-12-19 2004-07-08 Atherogenics, Inc. Process of making chalcone derivatives
US7173129B2 (en) * 2003-06-06 2007-02-06 Athero Genics, Inc. Sulfonamide-substituted chalcone derivatives and their use to treat diseases
WO2006004903A2 (en) * 2004-06-28 2006-01-12 Atherogenics, Inc. 1,2-bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof
WO2009122435A2 (en) * 2008-03-31 2009-10-08 Council Of Scientific & Industrial Research A simultaneous method for the preparation of a mixture of 3- acetoxy-17-acetamido-16-formyl-androst-5,17-diene and 3- acetoxy-2'-chloro-5-androsteno[17,16-b]pyridine
CN101817741B (zh) * 2009-12-10 2013-10-16 天津药物研究院 索法酮的晶型ⅸ及其制备方法和用途
CN101781194B (zh) * 2009-12-10 2013-05-15 天津药物研究院 索法酮的晶型ⅴ及其制备方法和用途
CN101792385B (zh) * 2009-12-10 2013-05-15 天津药物研究院 索法酮的晶型ⅷ及其制备方法和用途
CN101735038B (zh) * 2009-12-10 2013-06-26 天津药物研究院 索法酮的晶型ⅰ及其制备方法和用途
CN101735040B (zh) * 2009-12-10 2013-05-15 天津药物研究院 索法酮的晶型ⅲ及其制备方法和用途
CN101817742B (zh) * 2009-12-10 2013-10-16 天津药物研究院 索法酮的晶型ⅹ及其制备方法和用途
CN101735039B (zh) * 2009-12-10 2013-06-26 天津药物研究院 索法酮的晶型ⅱ及其制备方法和用途
CN101781195B (zh) * 2009-12-10 2013-03-13 天津药物研究院 索法酮的晶型ⅶ及其制备方法和用途
CN101781193B (zh) * 2009-12-10 2013-05-15 天津药物研究院 索法酮的晶型ⅳ及其制备方法和用途
CN101781192B (zh) * 2009-12-10 2013-05-15 天津药物研究院 索法酮的晶型ⅵ及其制备方法和用途
CN115368265B (zh) * 2022-10-24 2023-03-28 中国中医科学院中药研究所 一种索法酮小分子活性探针及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3255241A (en) * 1961-01-19 1966-06-07 Merck & Co Inc (2-alkylidene acyl)phenoxy-and (2-alkylidene acyl)phenylmercaptocarboxylic acids
CH593224A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1973-10-30 1977-11-30 Taisho Pharmaceutical Co Ltd

Also Published As

Publication number Publication date
YU39378B (en) 1984-12-31
AU2131077A (en) 1978-01-26
HU173019B (hu) 1979-01-28
CH605537A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-09-29
AR209544A1 (es) 1977-04-29
ES455620A1 (es) 1978-01-01
JPS5645896B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1981-10-29
US4085135A (en) 1978-04-18
DE2705603C2 (de) 1986-07-24
FR2340924A1 (fr) 1977-09-09
YU8977A (en) 1982-06-30
GB1523241A (en) 1978-08-31
JPS5297950A (en) 1977-08-17
PT66118A (en) 1977-02-01
PT66118B (en) 1978-06-28
DE2705603A1 (de) 1977-08-18
FR2340924B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1979-03-23

Similar Documents

Publication Publication Date Title
CA1084064A (en) Method for preparing 2'-(carboxymethoxy)-chalcones
CA1038763A (en) Pharmaceutical compositions comprising biphenyl derivatives
Hannah et al. Novel analgesic-antiinflammatory salicylates
AU2004212905B2 (en) Compounds for the treatment of metabolic disorders
US3928421A (en) Anti-gastric ulcer chalcone ethers
NZ222729A (en) Substituted catechol derivatives and pharmaceutical compositions
EA004931B1 (ru) 3, 4, 5-тризамещенные арилнитроны и содержащие их фармацевтические композиции
FI73965C (fi) Saett att framstaella nya terapeutiskt anvaendbara derivat av alifatiska fenylkarboxylsyror.
AU3883085A (en) Arylacetic acid derivatives
US5185370A (en) Substituted β-diketones and their use
JPH0227326B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
US4500731A (en) Derivatives of 4-phenyl-4-oxobuten-2-oic acid, pharmaceutical compositions containing them, and therapeutic uses for them
CA1328279C (en) Catechol carboxylic acid derivatives
US4255575A (en) 2-Hydroxy-5-(1-hydroxy-2-piperazinylethyl)-benzoic acid derivatives
US4029811A (en) Certain antiinflammatory dihydrobenzofuran and dihydronaphthofuran acetic acid compounds
US4116972A (en) Anti-inflammatory 1-oxo-isoindoline derivatives and processes for their preparation
KR810000953B1 (ko) 2'-(카복시메톡시)-칼콘류의 제법
SE455420B (sv) Anvendning av 4-fenyl-4-oxo-butensyraderivat for framstellning av ett lekemedel for behandling av magakommor och gastroduodenala akommor i samband med hyperaciditet
US4867737A (en) Derivatives of 4-phenyl-4-oxo-2-butenoic acid their preparation process, their use as medicaments and compositions containing them
EP1507523A1 (en) Cinnamic acid dimers, their preparation and the use thereof for treating neurodegenerative disease
US4065571A (en) Antiviral 5-(substituted benzal) hydantoins
CA1210021A (en) Terbutaline ester derivatives
JPS6045191B2 (ja) 新しい抗受精剤
US4317917A (en) Derivatives of methyl-substituted or methoxy-substituted 2-hydroxybenzoic acids, and pharmaceutical formulations containing them
US4283404A (en) Aroylethenylpiperidinobutyrophenone antipsychotic agents

Legal Events

Date Code Title Description
MKEX Expiry